{
  "catalogId": "bd42b6dd-a890-4d58-94b7-3be52c93000e",
  "name": "LIVTENCITY",
  "status": "",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "173 33 37360 99",
  "treatmentDescriptions": "LIVTENCITY is indicated for the treatment of adults and pediatric patients (12 years of age and older and weighing at least 35 kg) with post-transplant cytomegalovirus (CMV) infection/disease that is refractory to treatment (with or without genotypic resistance) with ganciclovir, valganciclovir, cidofovir or foscarnet.",
  "termsOfIssue": "Prescription required",
  "form": "film coated tablets",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "MARIBAVIR",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "J05AX10",
      "name": "MARIBAVIR"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "LIVTENCITY 200 MG 56 TAB",
      "manufacturer": {
        "name": "טקדה",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 56.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE POLYETHYLENE",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "9220",
        "yarpa": "24943",
        "pharmasoft": "12662"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 45089.12692,
        "retailMargin": 10.0,
        "maxRetailPrice": 49598.03961,
        "maxPriceWithVAT": 58525.68414
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T04:51:26.322244"
  }
}